• $1,241.00
    Market Cap
  • 0.00%
    1-Year Change
  • Biotechnology
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 27
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.000001
$0.000001
$0.000001
1-Year Range
$0.000001
$0.0001
$0.000001
Latest Close$0.000001
Change
-$0.00010 (-9,900.00%)
Volume2,275
Market Cap$1,241.00
Shares Outstanding1.2B
Enterprise Value$26,823.00

Information as of 07/22/2026

Company Profile

GLOBESTAR THERAPEUTICS CORP
https://www.globestartherapeutics.com
$1,241.00
Market Cap
-$886,956.00
Net Income
Sector: Healthcare
Industry: Biotechnology
1280 Lexington Avenue, New York, NY, United States, 10028
509-531-1671

GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, engages in the provision of patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases in the United States. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in New York, New York.

Key Executives

  • James C. Katzaroff
  • Brooke Greenwald
  • David Croom

Current Ownership Distribution

  • Other1.2B (94.44%)
  • Insiders68.0M (5.48%)
  • Institutions922,181 (0.07%)
  • Mutual Funds0 (0.00%)